rofecoxib has been researched along with Leg Dermatoses in 2 studies
Leg Dermatoses: A nonspecific term used to denote any cutaneous lesion or group of lesions, or eruptions of any type on the leg. (From Stedman, 25th ed)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Smith, KJ | 1 |
| Skelton, H | 1 |
| Lillicrap, MS | 1 |
| Merry, P | 1 |
2 other studies available for rofecoxib and Leg Dermatoses
| Article | Year |
|---|---|
Acute onset of neutrophilic dermatosis in patients after therapy with a COX-2-specific inhibitor.
Topics: Adult; Arthritis; Cyclooxygenase Inhibitors; Drug Eruptions; Female; Humans; Lactones; Leg Dermatose | 2003 |
Cutaneous vasculitis associated with rofecoxib.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Drug Eruptions; Female; Humans; Lactones; Leg Dermatoses; M | 2003 |